adenosine-pathway-immunotherapy.com
Open in
urlscan Pro
5.134.13.35
Public Scan
Submitted URL: https://info.hansonwade.com/e/448062/ntent-secondary-em-07-ev-25936/9y5xlh/1097009520?h=s-L8L6IJf11pIbAwxHkFUPibNVbpxRQy9umN...
Effective URL: https://adenosine-pathway-immunotherapy.com/?utm_source=internal&utm_medium=email&utm_campaign=other-companies-attending&utm_content=seconda...
Submission: On February 15 via manual from US — Scanned from DE
Effective URL: https://adenosine-pathway-immunotherapy.com/?utm_source=internal&utm_medium=email&utm_campaign=other-companies-attending&utm_content=seconda...
Submission: On February 15 via manual from US — Scanned from DE
Form analysis 1 forms found in the DOM
GET https://adenosine-pathway-immunotherapy.com/
<form role="search" method="get" id="searchform" class="searchform" action="https://adenosine-pathway-immunotherapy.com/">
<div>
<label class="screen-reader-text" for="s"> Search</label>
<input type="text" value="" name="s" id="s" placeholder="">
<input type="submit" id="searchsubmit" value="Search">
</div>
</form>Text Content
Skip to content
MAY 10 - 12, 2022
BOSTON, MA
BOOK WITH CONFIDENCE!
REGISTER BY FRIDAY, FEBRUARY 25 TO SAVE UP TO $1,300
Menu
* Home
* About
* About Event
* Venue
* FAQs
* What’s On?
* Full Event Guide
* Speakers
* Pre-Conference Workshop Day
* Agenda
* Day One
* Day Two
* Partner
* Partnership Opportunities
* Take Part
* Register
* Book With Confidence
* Contact Us
FULL EVENT GUIDE
REGISTER
PARTNERSHIPS
MAXIMIZE THE CLINICAL & COMMERCIAL OPPORTUNITY OF THE ADENOSINE-PATHWAY AS A
SECOND-GENERATION IMMUNO-ONCOLOGY TARGET
A plethora of showstopping clinical trial data readouts are being met with
refreshed excitement, enthusiasm and R&D investment for adenosine-pathway
targets, one of the most validated and established oncology pathways.
As such, the inaugural Adenosine-Pathway Targeted Cancer Immunotherapy Summit
has arrived as the definitive conference dedicated to optimizing efficacy of
adenosine-pathway targeted drugs, overcoming challenges of resistance and
immunosuppression and supercharging therapeutics into the clinic.
Uniting experts in adenosine, immune checkpoint, tumor microenvironment,
immune-oncology and second-generation IO, don’t miss your chance to investigate
adenosine signaling in the context of the hypoxic tumor microenvironment to
inform clinical advances, leverage biomarkers to evaluate disease and identify
patient responders for Adenosine-Pathway therapeutics.
Join fellow pioneers in the field to explore preclinical model landscapes and
gain a deeper understanding of the rationale of combination therapies to enhance
treatment potency & efficacy.
Don’t miss your chance to solve these challenges and maximize the clinical and
commercial opportunity of the adenosine-pathway.
WORLD-CLASS SPEAKER FACULTY INCLUDES:
KRIS SACHSENMEIER
Head, Oncology Translational Strategy: Cold-to-Hot
Takeda
RAKESH KUMAR
Global Project Leader
Astrazeneca
SALLY ROSS
Project Head
iTeos Therapeutics
MICHAIL SITKOVSKY
Professor & Director
Northeastern University
RICHARD MILLER
Chief Executive Officer
Corvus Pharmaceuticals
SIMON ROBSON
Professor of Medicine & Anesthesiology
Harvard Medical School, Scientific Founder Purinomia
See Full Speaker Faculty
Register
HEALTH & SAFETY
The health, safety and well-being of our community remains our highest priority,
therefore, all attendees will be required to complete a health declaration prior
to attending the event, as well as comply with the City of Boston’s B Together
policy. This policy requires individuals to show you proof of vaccination
against COVID-19 in order to gain admittance to the conference venue. For
further information around Health and Safety onsite, please visit our FAQs page
here or for more information on the B Together Policy, please see here.
* Please note, this is subject to change at any time without prior notice.
OUR CONTACT DETAILS
T: (+1) 617 455 4188
E: info@hansonwade.com
VENUE DETAILS
Omni Parker House
60 School St,
Boston, MA
02108, United States
ABOUT US
Hanson Wade's goal is to accelerate progress within organisations and across
industries. Our primary method for achieving this is by creating exclusive
business conferences that gather together the world's smartest thinkers and
doers.
LOCATION
SEARCH
Search
ORGANISED BY
Terms & Conditions
© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade
Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.
We use cookies to ensure that we give you the best experience on our website. If
you continue to use this site we will assume that you are happy with it.Ok